Medical Oncology

Campath-1H (Anti-CD52) Monoclonal Antibody Therapy in Lymphoproliferative Disorders: A Review
pp. 99-107(9)
Authors: Pangalis G.A.; Dimopoulou M.N.; Angelopoulou M.K.; Tsekouras C.; Vassilakopoulos T.P.; Vaiopoulos G.; Siakantaris M.P.

Serum S100 Protein as a Marker of Disease Activity in Patients with Malignant Melanoma
pp. 109-120(12)
Authors: Mohammed M.Q.; Abraha H.D.; Sherwood R.A.; MacRae K.; Retsas S.

Treatment of the T98G Glioblastoma Cell Line with Antisense Oligonucleotides Directed Toward mRNA Encoding Transforming Growth Factor- and the Epidermal Growth Factor Receptor
pp. 121-130(10)
Authors: Rubenstein M.; Glick R.; Lichtor T.; Mirochnik Y.; Chou P.; Guinan P.

Prevention of Delayed Emesis Induced by Moderately Emetogenic Chemotherapy in Patients with Acute Emesis: A Pilot Study with ACTH-Depot Plus Tropisetron
pp. 131-135(5)
Authors: Santini D.; Vincenzi B.; Fossati C.; D'Angelillo R.M.; Patti G.; Bianco V.; Avvisati G.; Tonini G.

Rituximab (Mabthera™, Rituxan™) in Patients with Recurrent Indolent Lymphoma: Evaluation of Safety and Efficacy in a Multicenter Study
pp. 141-148(8)
Authors: Walewski J.; Kraszewska E.; Mioduszewska O.; Romejko-Jarosiska J.; Hellmann A.; Czyz J.; Holowiecki J.; Kopera M.; Grosicki S.; Komarnicki M.; Rumianowski L.; Kuliczkowski K.; Wróbel T.; Dwilewicz-Trojaczek J.; Robak T.; Warzocha K.; Zaluski J.; Wójcik E.; Dmoszyska A.; Walter-Croneck A.

Tumor Lysis Syndrome in Small Cell Lung Cancer
pp. 149-151(3)
Authors: Kallab A.M.; Jillella A.P.

Bilateral Chylothorax Due to Retrosternal Goiter in a Patient with Non-Hodgkin's Lymphoma
pp. 153-157(5)
Authors: Simmgen M.; Newlands E.S.; Southcott B.M.; Vigushin D.M.

Metastases in Small Thickness Oral Squamous-Cell Carcinoma Arising in Oral Lichen Planus
pp. 159-163(5)
Authors: Mignogna M.D.; Muzio L.L.; Russo L.L.; Fedele S.; Ruoppo E.; Bucci E.

Choriocarcinoma of the Gallbladder: Treated with Cisplatin-Based Chemotherapy
pp. 165-169(5)
Authors: Wang J.C.; Angeles S.; Chak P.; Platt A.B.; Nimmagadda N.